Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review

Современные проблемы легочной инфекции, вызванной нетуберкулезными микобактериями: серия клинических случаев с обзором литературы
Teena Chopra, Mark L. Metersky, David Fraulino, Lea Monday
2024-09-11

Mycobacterium avium compleximmunomodulatory therapymultidrug treatment regimensnontuberculous mycobacterial pulmonary diseasepatient-centered interdisciplinary care
BACKGROUND: The prevalence of nontuberculous mycobacteria pulmonary disease (NTM-PD), particularly caused by Mycobacterium avium complex (MAC), is rising due to improved diagnostics, increased awareness, and more susceptible populations. NTM-PD significantly affects quality of life and imposes substantial economic costs. Understanding its clinical features, risk factors, and treatment challenges is vital for enhancing patient outcomes. PATIENTS AND METHODS: A convenience sample from the University of Connecticut Health Center and Wayne State University involving patients with NTM-PD from 2021 to 2024 was studied retrospectively. Cases were selected to demonstrate typical diagnostic and treatment challenges, followed by a multidisciplinary roundtable discussion to examine patient-centered care strategies. RESULTS: Analysis of six cases pinpointed chronic lung conditions and immunomodulatory therapy as key risk factors. Standard treatment, involving extensive multi-drug regimens, frequently results in poor adherence due to side effects and complex management requirements. The discussions underlined the importance of a customized, interdisciplinary approach to improve treatment effectiveness and patient quality of life. CONCLUSIONS: NTM-PD is an escalating public health issue with notable clinical and economic consequences. Managing this disease effectively demands a comprehensive, patient-centered strategy that includes precise diagnosis, flexible treatment plans, and collaborative care.
1
A customized, interdisciplinary, patient-centered approach is emphasized to improve treatment effectiveness and quality of life.
2
Chronic lung disease and immunomodulatory therapy were identified as key risk factors for pulmonary nontuberculous mycobacterial disease.
3
NTM-PD is an escalating public health problem with substantial clinical and economic consequences, requiring precise diagnosis and flexible treatment plans.
4
Six retrospective cases illustrated recurring diagnostic and treatment challenges in NTM-PD, particularly involving Mycobacterium avium complex.
5
Standard NTM-PD treatment requires extensive multidrug regimens that frequently cause poor adherence because of adverse effects and complex management.

pulmonary nontuberculous mycobacterial disease, particularly Mycobacterium avium complex infection

clinical features, risk factors, treatment challenges, and patient-centered management of the disease

Publication Details
Publication Date
2024-09-11
Journal
Publisher
ISSN
Cited by
9
Access Type
Author Information
Authors
Teena Chopra
Mark L. Metersky
David Fraulino
Lea Monday
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%